Healthcare - Biotechnology - NASDAQ - US
$ 25.05
-12 %
$ 3.61 B
Market Cap
-9.08
P/E
Price Target
Average
39.72%
Revenue Forecast
Estimate
18.66%
EBIT
Estimate
--22.92%
Net Income
Estimate
33.34%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Denali Therapeutics Inc.
Wall Street analysts predict an average 1-year price target for DNLI of $35 , with forecasts ranging from a low of $22 to a high of $46 .
DNLI Lowest Price Target
Wall Street Target
22 USD
-12.18%
DNLI Average Price Target
Wall Street Target
35 USD
39.72%
DNLI Highest Price Target
Wall Street Target
46 USD
83.63%
REVENUE FORECAST
Revenue Forecast Chart DNLI
EBIT FORECAST
EBIT Forecast Chart DNLI
NET INCOME FORECAST
Net Income Chart DNLI